ArticleDEN open2026
Complications of Endoscopic Pressure Study Integrated System: Review of 1205 Cases in 10 Years' Experience.
Article in DEN open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Changes in endoscopic pressure study integrated system (EPSIS) parameters after antireflux surgery and their association with postoperative clinical outcomes.Surgical endoscopy · 2026Article
- Article
- Diagnosis of Functional Dyspepsia and Novel Gastrointestinal Functional Assessments.Digestion · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: The Endoscopic Pressure Study Integrated System (EPSIS) is a novel endoscopic tool to assess lower esophageal sphincter (LES) function by monitoring intragastric pressure (IGP) through insufflation. While previous studies have confirmed its diagnostic utility for LES dysfunction-related disorders such as gastroesophageal reflux disease and achalasia, there have been no reports evaluating its safety. Thus, this study aimed to assess its complication rates and detailed characteristics. Methods: We retrospectively reviewed 1205 consecutive EPSIS cases performed between December 2015 and September 2024 at our institution. Cases with adverse events (AEs) were identified, and clinical characteristics, waveform patterns, IGP parameters, and need for additional treatment were analyzed. Results: AEs occurred in 35 cases (2.9%), including 32 cases (2.7%) of micro-mucosal bleedings (MMBs) and three cases (0.25%) of superficial mucosal tears (SMTs). All cases were minor (Clavien-Dindo grade I), without the need for any additional intervention. All 35 cases exhibited an uphill waveform. SMTs were associated with pressure spikes due to vomiting or belching. No serious AEs, including perforations or active bleeding, were observed. Conclusions: EPSIS is a safe and minimally invasive procedure, with low complication rates comparable to routine upper endoscopy. To maintain its safety, EPSIS should be performed under sedation with CO₂ insufflation. In addition, insufflation during EPSIS should be controlled so that the IGP is maintained less than 25 mmHg. However, this threshold may vary depending on the patient's underlying conditions or clinical background; therefore, further research is warranted. Clinical Trial Registration: N/A.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.